Mount Yale Investment Advisors LLC Trims Holdings in CVS Health Co. (NYSE:CVS)

Mount Yale Investment Advisors LLC lessened its stake in CVS Health Co. (NYSE:CVS - Free Report) by 93.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,915 shares of the pharmacy operator's stock after selling 87,663 shares during the period. Mount Yale Investment Advisors LLC's holdings in CVS Health were worth $266,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also added to or reduced their stakes in the company. Farmers National Bank increased its position in shares of CVS Health by 5.9% during the second quarter. Farmers National Bank now owns 97,817 shares of the pharmacy operator's stock worth $5,777,000 after purchasing an additional 5,453 shares in the last quarter. Strategic Investment Solutions Inc. IL purchased a new position in CVS Health during the 2nd quarter worth $63,000. Brown Financial Advisors purchased a new stake in CVS Health in the second quarter valued at about $684,000. Sanctuary Advisors LLC purchased a new stake in shares of CVS Health during the second quarter worth about $8,005,000. Finally, Prio Wealth Limited Partnership increased its holdings in shares of CVS Health by 1.1% during the second quarter. Prio Wealth Limited Partnership now owns 57,413 shares of the pharmacy operator's stock valued at $3,391,000 after acquiring an additional 600 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Price Performance

Shares of CVS Health stock traded down $0.06 during trading hours on Thursday, reaching $56.84. The stock had a trading volume of 11,112,934 shares, compared to its average volume of 13,509,735. The firm has a market capitalization of $71.53 billion, a PE ratio of 14.43, a PEG ratio of 0.80 and a beta of 0.59. The stock's 50 day moving average is $51.28 and its 200 day moving average is $56.17. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company's revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm posted $2.21 earnings per share. Equities analysts expect that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.68%. CVS Health's payout ratio is currently 67.51%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on CVS shares. TD Cowen boosted their target price on shares of CVS Health from $73.00 to $80.00 and gave the stock a "buy" rating in a research report on Monday, November 25th. UBS Group boosted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the company a "neutral" rating in a report on Thursday, November 7th. Mizuho lowered their price target on CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a research report on Thursday, October 24th. Edward Jones raised CVS Health from a "hold" rating to a "buy" rating in a report on Thursday. Finally, Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $68.12.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.